Suchergebnisse - "Lan, Chunyan"

PubPharm (35)

1

Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer

enthalten in: BMC genomics | 2024

von Pei, J. | Peng, Y. | Ma, K. | +5

2

Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Wei, Y. | Liang, H. | Liu, S. | +7

3

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer : a multicenter, open-label, single-arm, phase II trial

enthalten in: EClinicalMedicine | 2023

von Wang, Y. | Zhao, J. | Liang, H. | +5

4

Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer : protocol of a multicenter, open-label, randomized phase 2 trial

enthalten in: Translational cancer research | 2023

von Hou, Z. | Lan, C. | Huang, X. | +2

5

The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages

enthalten in: Cancer cell international | 2023

von Pan, B. | Wan, T. | Zhou, Y. | +12

6

Absolute quantification of 2-hydroxyglutarate on tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging for rapid and precise identification of isocitrate dehydrogenase mutations in human glioma

enthalten in: International journal of cancer | 2021

von Lan, C. | Li, H. | Wang, L. | +8

7

Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy : a secondary analysis of the CLAP trial

enthalten in: Journal for immunotherapy of cancer | 2021

von Huang, X. | He, M. | Peng, H. | +9

ErratumIn: J Immunother Cancer. 2022 Feb;10(2):. - PMID 35173032

8

Development and Validation of a Nomogram Based on CA125 Levels for Predicting Progression-Free Survival in Patients with Ovarian Cancer

enthalten in: ResearchSquare.com | 2021

von He, M. | Xie, C. | Huang, J. | +3

9

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP) : A Multicenter, Open-Label, Single-Arm, Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Lan, C. | Shen, J. | Wang, Y. | +15

10

Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer : an exploratory imaging biomarker analysis of the AEROC trial

enthalten in: BMC medicine | 2020

von Huang, X. | Xie, C. | Tang, J. | +8